The mortality rate for colon, rectum, and anus malignant neoplasms in German women is projected to decline steadily, from 14.4 deaths per 100,000 in 2024 to 12.2 in 2028. This indicates an encouraging trend, with an anticipated year-on-year reduction averaging around 3-4% as mortality rates drop by 0.5 to 0.6 units annually during this period. The compound annual growth rate (CAGR) over the five years suggests a consistent decrease in mortality by approximately 3.2% each year.
Future trends to watch for include advancements in early detection and treatment technologies, lifestyle changes, and public health campaigns focusing on prevention and awareness. Emerging healthcare policies and research initiatives could potentially accelerate these declines beyond current projections.
